Sponsored Content
ugichem Closes € 2m Financing Round
Sponsored Content
The Tyrolean biotech company secured funding from two major investors and a research grant from the Austrian Research Promotion Agency.

Innsbruck-based ugichem announced the closing of a € 2m follow-up financing. The present lead investor The BioScience Venture Group and the new investor V+ GmbH & Co Fonds 3 KG participated in this € 1.4m equity financing round as well as notable Swiss private investors. Additionally ugichem received a € 0.6m research grant from the Austrian Research Promotion Agency…
or Log In
Sponsored Content
Sponsored Content
Sponsored Content
Fast News Search
Related News
Intercell Is Looking for Financial Investors (July 19, 2011)
Intercell to Cut Jobs and Research Budget (June 8, 2011)
R&D: High Activities of Austrian Firms with Foreign Co-Investors (January 4, 2011)
Economic Chamber in Tokyo: Biotechnology as an Opportunity (December 6, 2010)
Expansion Potential of Austrian Pharmaceutical Industry in Japan (December 1, 2010)
Sponsored Content
Read More
Featured